eyestock logo

eyestock

BA

Bal Pharma LtdNSE BALPHARMA

Последний отчетный период 30 сент., 2023

Обновлено 23 окт., 2024

Последняя цена

Капитализация млрд. $

0.006

Micro

Биржа

XNSE - National Stock Exchange Of India

Анализ акций BALPHARMA.NS

BA

Нет оценки

Количественный анализ Eyestock не покрывает акции Bal Pharma Ltd.

Капитализация млрд. $

0.006

Дивидендная доходность

0.90 %

Оборот

15.804 млрд

Сайт компании

https://www.balpharma.com/

Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The firm is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). The company is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. The company offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The firm offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.

Смотреть Секцию: Рейтинг